Massimiliano Mazza

9PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Noise and wave pollution processes and measurementInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2026
Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.

Alessandra Virga, Flavia Foca, Stefania Cortecchia

|Oct 16, 2025
Special Issue "The Promising Future of CAR-Based Therapies: A Matter of Molecular Details".

Fabio Nicolini, Orsola Montini, Matteo Zurlo

|Jan 14, 2025
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity.

Lucia Mazzotti, Patricia Borges de Souza, Irene Azzali

|Nov 27, 2024
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.

Anna Gaimari, Anna De Lucia, Fabio Nicolini

|Mar 28, 2024
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy.

Roberta Maltoni, Andrea Roncadori, William Balzi

|Nov 11, 2022
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.

Massimo Martino, Virginia Naso, Barbara Loteta

Pageof 2

Frequent Collaborators

5 joint publications

Fabio Nicolini

4 joint publications

Giovanni Martinelli

4 joint publications

Claudio Cerchione

4 joint publications

Sara Bravaccini